OpenURL Connection Search

Select item for more details and to access through your institution.

HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection.
Published in:
International Immunology, 2003, v. 15, n. 10, p. 1125, doi. 10.1093/intimm/dxg117
By:
- D. Loirat;
- M. Mancini-Bourgine;
- Abastado J.-P.;
- Michel M.-L.
Publication type:
Article
Immunothérapie et cancer du sein.
Published in:
Oncologie (Tech Science Press), 2016, v. 18, n. 9/10, p. 551, doi. 10.1007/s10269-016-2663-z
By:
- Verret, B.;
- Loirat, D.
Publication type:
Article
Nivolumab versus everolimus dans le carcinome à cellules rénales au stade avancé.
Published in:
Oncologie (Tech Science Press), 2016, v. 18, n. 2/3, p. 196
By:
- Hirsch, L.;
- Loirat, D.
Publication type:
Article
Immunothérapie anticancer : les molécules immunomodulatrices en développement clinique.
Published in:
Oncologie (Tech Science Press), 2015, v. 17, n. 9, p. 379, doi. 10.1007/s10269-015-2546-8
By:
- Loirat, D.;
- Tourneau, C.
Publication type:
Article
Congrès Targeted Anticancer Therapies - TAT 2014.
Published in:
2014
By:
- Bellesoeur, A.;
- Brunot, A.;
- Calcagno, F.;
- Grellety, T.;
- Loirat, D.;
- Tabouret, E.;
- Tlemsani, C.;
- Sajous, C.;
- Vicier, C.;
- Rousseau, B.;
- Soria, J.
Publication type:
Report
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer.
Published in:
British Journal of Cancer, 2024, v. 131, n. 4, p. 702, doi. 10.1038/s41416-024-02766-9
By:
- Poumeaud, F.;
- Morisseau, M.;
- Cabel, L.;
- Gonçalves, A.;
- Rivier, C.;
- Trédan, O.;
- Volant, E.;
- Frenel, J.-S.;
- Ladoire, S.;
- Jacot, W.;
- Jamelot, M.;
- Foka Tichoue, H.;
- Patsouris, A.;
- Teixeira, L.;
- Bidard, F.-C.;
- Loirat, D.;
- Brunet, M.;
- Levy, C.;
- Bailleux, C.;
- Cabarrou, B.
Publication type:
Article
A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma.
Published in:
British Journal of Cancer, 2023, v. 128, n. 6, p. 1040, doi. 10.1038/s41416-022-02133-6
By:
- Piperno-Neumann, S.;
- Carlino, M. S.;
- Boni, V.;
- Loirat, D.;
- Speetjens, F. M.;
- Park, J. J.;
- Calvo, E.;
- Carvajal, R. D.;
- Nyakas, M.;
- Gonzalez-Maffe, J.;
- Zhu, X.;
- Shirley, M. D.;
- Ramkumar, T.;
- Fessehatsion, A.;
- Burks, H. E.;
- Yerramilli-Rao, P.;
- Kapiteijn, E.
Publication type:
Article

Found: 7

HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection.

Immunothérapie et cancer du sein.

Nivolumab versus everolimus dans le carcinome à cellules rénales au stade avancé.

Immunothérapie anticancer : les molécules immunomodulatrices en développement clinique.

Congrès Targeted Anticancer Therapies - TAT 2014.

Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer.

A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma.